Stocks and InvestingStocks and Investing
Wed, February 28, 2024
Tue, February 27, 2024

Suraj Kalia Maintained (TMDX) at Buy with Increased Target to $105 on, Feb 27th, 2024


Published on 2024-10-28 09:13:43 - WOPRAI, Suraj Kalia
  Print publication without navigation


Suraj Kalia of Oppenheimer, Maintained "TransMedics Group, Inc." (TMDX) at Buy with Increased Target from $92 to $105 on, Feb 27th, 2024.

Suraj has made no other calls on TMDX in the last 4 months.



There are 2 other peers that have a rating on TMDX. Out of the 2 peers that are also analyzing TMDX, 1 agrees with Suraj's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Cecilia Furlong of "Morgan Stanley" Maintained at Hold with Increased Target to $75 on, Monday, December 4th, 2023


This is the rating of the analyst that currently disagrees with Suraj


  • Thomas Allen of "JP Morgan" Maintained at Buy with Increased Target to $70 on, Tuesday, November 7th, 2023